Quisinostat


CAS No. : 875320-29-9

(Synonyms: JNJ-26481585)

875320-29-9
Price and Availability of CAS No. : 875320-29-9
Size Price Stock
5mg $158 In-stock
10mg $230 In-stock
25mg $395 In-stock
50mg $554 In-stock
100mg $770 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-15433
M.Wt: 394.47
Formula: C21H26N6O2
Purity: >98 %
Solubility: DMSO : 41.67 mg/mL (ultrasonic;warming;heat to 60°C)
Introduction of 875320-29-9 :

Quisinostat (JNJ-26481585) is a potent and orally active pan-HDAC inhibitor (HDACi), with IC50 values ranging from 0.11 nM to 0.64 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11. Quisinostat has a broad spectrum antitumoral activity[1]. Quisinostat can induce autophagy in neuroblastoma cells[2]. IC50 & Target:IC50: 0.11 nM (HDAC1), 0.33 nM (HDAC2), 0.64 nM (HDAC4), 0.46 nM (HDAC10), 0.37 nM (HDAC11)[1] In Vitro:Quisinostat inhibits HDAC isozymes in vitro[1].
Quisinostat (30-1000 nM; 24 hours) is a potent pan-HDAC inhibitor in tumor cells[1].
Quisinostat has a broad spectrum antiproliferative activity against solid and hematologic cancer cell lines and induces apoptosis[1].
In Vivo:Quisinostat (40 mg/kg; p.o.; once daily; for 3 days) acts as a potent HDAC1 inhibitor that inhibits p21waf1,cip1 ZsGreen tumors in vivo[1].
Quisinostat induces continuous H3 acetylation in tumor tissue in vivo[1].
Quisinostat (10 mg/kg; once daily; i.p.; for 14 days) strongly inhibits the growth of large pre-established HCT116 colon xenografts[1].

Your information is safe with us.